[go: up one dir, main page]

CU20110044A7 - N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] POLYMORPH B BENZAMIDE (MS-275) - Google Patents

N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] POLYMORPH B BENZAMIDE (MS-275)

Info

Publication number
CU20110044A7
CU20110044A7 CU20110044A CU20110044A CU20110044A7 CU 20110044 A7 CU20110044 A7 CU 20110044A7 CU 20110044 A CU20110044 A CU 20110044A CU 20110044 A CU20110044 A CU 20110044A CU 20110044 A7 CU20110044 A7 CU 20110044A7
Authority
CU
Cuba
Prior art keywords
aminophenyl
benzamide
methyl
polymorph
metoxicarbonylamine
Prior art date
Application number
CU20110044A
Other languages
Spanish (es)
Other versions
CU24049B1 (en
Inventor
Jens Geisler
Gabriele Winter
Michael Gottfried
Matthias Schneider
Original Assignee
Bayer Schering Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/006381 external-priority patent/WO2010022988A1/en
Application filed by Bayer Schering Pharma AG filed Critical Bayer Schering Pharma AG
Publication of CU20110044A7 publication Critical patent/CU20110044A7/en
Publication of CU24049B1 publication Critical patent/CU24049B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

El polimorfo B cristalino de N-(2-aminofenil)-4-[N-(piridin-3-il)metoxicarbonilamino-metil]benzamida (MS-275) de fórmula I ESPACIO PARA LA FÓRMULA así como el proceso para producir dicho compuesto, y su uso como medicamento para tratar ciertas enfermedades.The crystalline polymorph B of N- (2-aminophenyl) -4- [N- (pyridin-3-yl) methoxycarbonylamino-methyl] benzamide (MS-275) of formula I SPACE FOR FORMULA as well as the process for producing said compound , and its use as a medicine to treat certain diseases.

CU2011000044A 2008-08-29 2011-02-28 POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275) CU24049B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9304608P 2008-08-29 2008-08-29
PCT/EP2009/006381 WO2010022988A1 (en) 2008-08-29 2009-08-27 N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b

Publications (2)

Publication Number Publication Date
CU20110044A7 true CU20110044A7 (en) 2011-12-28
CU24049B1 CU24049B1 (en) 2014-12-26

Family

ID=40791975

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2011000044A CU24049B1 (en) 2008-08-29 2011-02-28 POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275)

Country Status (2)

Country Link
CU (1) CU24049B1 (en)
GB (1) GB2462893B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2977492B1 (en) * 2011-07-04 2013-07-05 Servier Lab NOVEL ASSOCIATION BETWEEN N-HYDROXY-4- {2- [3- (N, N-DIMETHYLAMINOMETHYL) BENZOFURAN-2-YLCARBONYLAMINO] ETHOXY} BENZAMIDE AND FOLFOX

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JP2001064177A (en) * 1999-08-16 2001-03-13 Schering Ag Pharmaceutical preparation including benzamide derivative as ingredient
JP4360660B2 (en) * 1999-11-09 2009-11-11 三井化学株式会社 Purification method of monoacylphenylenediamine derivatives
PE20050206A1 (en) * 2003-05-26 2005-03-26 Schering Ag PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF HISTONE DEACETILASE

Also Published As

Publication number Publication date
GB0907347D0 (en) 2009-06-10
GB2462893B (en) 2010-10-13
GB2462893A (en) 2010-03-03
CU24049B1 (en) 2014-12-26

Similar Documents

Publication Publication Date Title
CR20160465A (en) POLYMORPH B OF THE N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] BENZAMIDE (MS-275)
CO6311079A2 (en) AMINODIHYDROTIAZINE DERIVATIVES AS INHIBITORS OF THE BACE ENZYME FOR THE TREATMENT OF ALZHEIMER'S DISEASE
CU24083B1 (en) USEFUL OXAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
BR112014005468A2 (en) aminopyridine derivatives for use as modulators of kinase activity
CO6771439A2 (en) Benzodioxane inhibitors of leukotriene production
DOP2009000287A (en) OXAZOLIDINONES REPLACED AND ITS USE
CU20110083A7 (en) FUSIONED SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
DK2150530T3 (en) Substituted sulfonamide derivatives
EA201391525A1 (en) GLYCOSIDE DERIVATIVES AND THEIR APPLICATION FOR THE TREATMENT OF DIABETES
CR11452A (en) 5 - ((3,3,3-TRIFLUORO-2-HIDROXI-1-ARILPROPIL) AMINO) -1H-QUINOLIN-2-ONAS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTIFLAMATORY AGENTS
ECSP11010992A (en) ANILINA-PYRIMIDINE DERIVATIVES SUBSTITUTED WITH SULFOXIMINE AS INHIBITORS OF CYCLINE-DEPENDENT KINASE (CDK), PRODUCTION AND USE OF THE SAME AS MEDICINAL PRODUCTS
CU23757B7 (en) BENCILAMINS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTI-INFLAMMATORY AGENTS
BR112014005554A2 (en) imidazole amines as modulators of kinase activity
CL2011001829A1 (en) 3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound.
CU20110108A7 (en) [4- (1-AMINO-ETIL) -CICLOHEXIL] -METIL-AMINAS AS ANTIBACTERIALS
CR20120274A (en) HYDROCHLORIDE HYDROCHLORIDE SYSTESIS AND CRYSTAL PROCEDURE OF 4- {3 [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2- (1H) -IL] PROPOXI} BENZAMIDE AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
ECSP088153A (en) NEW DERIVATIVES OF PIPERIDINA
CO6390054A2 (en) CRYSTAL FORMS OF A 3-CARBOXIPROPIL-AMINOTETRALINE COMPOUND
CU20110044A7 (en) N- (2-AMINOPHENYL) -4- [N- (PIRIDIN-3-IL) METOXICARBONYLAMINE-METHYL] POLYMORPH B BENZAMIDE (MS-275)
UA98884C2 (en) N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275) polymorph b
TN2011000091A1 (en) N-(2-aminophenyl)-4-[n-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (ms-275)polymorph b
DOP2009000007A (en) BENCILAMINS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTINFLAMATORY AGENTS

Legal Events

Date Code Title Description
FG Grant of patent